These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Taylor CW, Dalton WS, Parrish PR, Gleason MC, Bellamy WT, Thompson FH, Roe DJ, Trent JM. Br J Cancer; 1991 Jun; 63(6):923-9. PubMed ID: 1676902 [Abstract] [Full Text] [Related]
9. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation. Zarcone D, Viale O, Cerruti G, Tenca C, Malorni W, Arancia G, Iosi F, Galandrini R, Velardi A, Moretta A. Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897 [Abstract] [Full Text] [Related]
10. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity. Azuma A, Yagita H, Matsuda H, Okumura K, Niitani H. Cancer Res; 1992 Sep 15; 52(18):4890-4. PubMed ID: 1381273 [Abstract] [Full Text] [Related]
11. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells. Komatsu F, Kajiwara M. Oncol Res; 1998 Sep 15; 10(10):483-9. PubMed ID: 10338151 [Abstract] [Full Text] [Related]
14. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity. Galandrini R, Albi N, Zarcone D, Grossi CE, Velardi A. Eur J Immunol; 1992 Aug 15; 22(8):2047-53. PubMed ID: 1379184 [Abstract] [Full Text] [Related]
15. Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants. Gross N, Favre S, Beck D, Meyer M. Int J Cancer; 1992 Aug 19; 52(1):85-91. PubMed ID: 1354203 [Abstract] [Full Text] [Related]
16. CD18/CD54(+CD102), CD2/CD58 pathway-independent killing of lymphokine-activated killer (LAK) cells against glioblastoma cell lines T98G and U373MG. Komatsu F, Kajiwara M. Oncol Res; 2000 Aug 19; 12(1):17-24. PubMed ID: 11061342 [Abstract] [Full Text] [Related]
17. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz J. J Immunol; 1990 Nov 15; 145(10):3194-201. PubMed ID: 1700001 [Abstract] [Full Text] [Related]
18. Role of LFA-3, ICAM-1, and MHC class I on the sensitivity of human tumor cells to LAK cells. Gwin JL, Gercel-Taylor C, Taylor DD, Eisenberg B. J Surg Res; 1996 Jan 15; 60(1):129-36. PubMed ID: 8592403 [Abstract] [Full Text] [Related]
19. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1. Triozzi PL, Eicher DM, Smoot J, Rinehart JJ. Exp Hematol; 1992 Oct 15; 20(9):1072-6. PubMed ID: 1361453 [Abstract] [Full Text] [Related]
20. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Altomonte M, Gloghini A, Bertola G, Gasparollo A, Carbone A, Ferrone S, Maio M. Cancer Res; 1993 Jul 15; 53(14):3343-8. PubMed ID: 7686816 [Abstract] [Full Text] [Related] Page: [Next] [New Search]